or animal models. Nanoparticles were initially considered as benign carriers, but multiple studies
have demonstrated that their interaction with serum proteins and cell membrane receptors is
determined by the nanoparticle design, in effect influencing cell uptake, gene expression, and
toxicity.Nanoparticles can interact with the cell surface membrane in multiple scenarios, as shown
in